The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 06, 2022

Filed:

Sep. 25, 2017
Applicant:

National University Corporation Tokyo Medical and Dental University, Tokyo, JP;

Inventors:

Takanori Yokota, Tokyo, JP;

Tetsuya Nagata, Tokyo, JP;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 48/00 (2006.01); A61K 31/711 (2006.01); A61K 47/22 (2006.01); A61K 47/28 (2006.01); C12N 15/113 (2010.01); A61K 47/54 (2017.01); A61P 25/00 (2006.01); A61K 31/7088 (2006.01); C12N 15/09 (2006.01); A61P 27/02 (2006.01); A61K 9/00 (2006.01); A61K 31/7125 (2006.01);
U.S. Cl.
CPC ...
A61K 31/711 (2013.01); A61K 9/0019 (2013.01); A61K 31/7088 (2013.01); A61K 31/7125 (2013.01); A61K 47/22 (2013.01); A61K 47/28 (2013.01); A61K 47/542 (2017.08); A61K 47/554 (2017.08); A61K 48/00 (2013.01); A61P 25/00 (2018.01); A61P 27/02 (2018.01); C12N 15/09 (2013.01); C12N 15/113 (2013.01);
Abstract

The present invention provides a composition and a method for efficiently delivering a nucleic acid agent to the central nervous system and/or the retina and bringing about antisense effects. Provided is a composition for reducing the expression level of a target transcription product in the central nervous system and/or retina of a subject, the composition including a nucleic acid complex that includes a first nucleic acid strand and a second nucleic acid strand, wherein: the first nucleic acid strand comprises a base sequence capable of hybridizing with at least part of the target transcription product and has an antisense effect on the target transcription product; the second nucleic acid strand comprises a base sequence complementary to the first nucleic acid strand and is conjugated to tocopherol, cholesterol, or an analog thereof; and the first nucleic acid strand is annealed to the second nucleic acid strand.


Find Patent Forward Citations

Loading…